Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa Reclamada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leer más
My experience within my department has been fantastic. Cross functional interactions have often been good. Experiences with the prior executive team make-up were, at times, excruciating. I have great hope for the executive new team, however.
¿Qué es lo que te hace más feliz en el trabajo?
Being able to get things done for patients
Revisión
¿Qué es lo más positivo de la cultura y el ambiente de tu empresa?
It is stabilizing after years of being completely untenable. If I were based in the office, it is likely I would have moved on long ago.
Revisión
¿Qué es lo mejor de tu paquéte de compensación?
Great $ matching. Healthcare is excellent although difficult to manage in NYS. Wishing that there were more options based on field distribution (at same level of quality).
Revisión
¿Qué son algunas de las mejores cosas de tu equipo?
My team in particular has been incredibly stable for the last 5 years which is totally a result of the quality of our department head and in the people that we have hired. They have become family, not just coworkers and we all collaborate REALLY well.
Revisión
¿Qué es lo que más te gusta de tu equipo directivo?
The leadership team has become more stable over the last year. They seem to be realigning corporate strategy to that of a commercial entity rather than a start-up. The company culture has also become more stable and you can actually feel a collective sigh of relief.
Revisión
Other Employee Reviews for Karyopharm Therapeutics
×